GlassScriptPhysician profile
Glenn A Ridder
NPI 1003816885
$1,265.23
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $661 · 2020: $48.95 · 2023: $211 · 2024: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $470 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $469.80 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $241.22 | 2019-2024 | Mounjaro, Zepbound |
| Amgen INC. | $168.17 | 2019-2023 | Evenity, Prolia |
| Merck Sharp & Dohme LLC | $130.93 | 2019 | |
| Abbvie INC. | $108.50 | 2023-2024 | |
| Daiichi Sankyo INC. | $99.31 | 2020-2024 | Injectafer |
| Actelion Pharmaceuticals US, INC. | $84.99 | 2024 | Opsumit, Uptravi |
| Sunovion Pharmaceuticals INC. | $80.66 | 2019 | |
| Pfizer INC. | $56.32 | 2019-2024 | |
| Novo Nordisk INC | $49.38 | 2019-2023 | Wegovy |
| Astellas Pharma US INC | $44.06 | 2023-2024 | Veozah |
| Grifols USA, LLC | $29.64 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.34 | 2019-2024 | Xarelto |
| Dexcom, INC. | $26.13 | 2023 | Dexcom G6 Transmitter |
| Regeneron Healthcare Solutions, INC. | $25.89 | 2019 | |
| Allergan, INC. | $24.95 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $24.92 | 2024 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $16.01 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.45 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Ridder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.